Showing results (211-220 of 417) with videos related to
Sort By:
Pageof 42
Hepatology (Baltimore, Md.)|January 7, 2014
Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic ratsLaura Coch, Marc Mejias, Annalisa Berzigotti, et al.Scientific Reports|February 10, 2024
Landscape connectivity for predicting the spread of ASF in the European wild boar populationTeresa Goicolea, Pablo Cisneros-Araújo, Cecilia Aguilar Vega, et al.Hepatology (Baltimore, Md.)|July 22, 2014
Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis CEmmanuel A Tsochatzis, Catriona Crossan, Louise Longworth, et al.Hepatology (Baltimore, Md.)|December 24, 2005
Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosisJuan Turnes, Manuel Hernández-Guerra, Juan G Abraldes, et al.Hepatology (Baltimore, Md.)|November 25, 2015
Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trialÀngels Escorsell, Oana Pavel, Andrés Cárdenas, et al.Journal of Wildlife Diseases|June 6, 2022
Coinfection of Chytrid Fungi in Urodeles during an Outbreak of Chytridiomycosis in SpainMaria P Ribas, Oscar Cabezón, Roser Velarde, et al.Hepatology (Baltimore, Md.)|February 24, 2006
Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertensionManuel Hernández-Guerra, Juan C García-Pagán, Juan Turnes, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2023
Health-related Quality of Life in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Multi-center UK StudyMargarita Papatheodoridi, Giada Pallini, Guruprasad Aithal, et al.Journal of Hepatology|December 17, 2014
Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertensionBogdan Procopet, Annalisa Berzigotti, Juan G Abraldes, et al.Journal of Hepatology|June 7, 2008
Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic ratsVasilica Matei, Aina Rodríguez-Vilarrupla, Ramon Deulofeu, et al.Pageof 42